柴胡皂苷通过结合并抑制P2X7减轻抑郁模型中小胶质细胞焦亡
本研究探讨柴胡(Bupleurum scorzonerifolium Willd.)中柴胡皂苷(SSs)的抗抑郁机制。采用LPS腹腔注射建立小鼠抑郁模型及LPS+ATP诱导N9细胞模型,发现SSs可改善抑郁样行为、减轻中枢炎症并抑制神经元焦亡。机制上SSs能降低抑郁小鼠脑内P2X7表达并增强N9细胞中P2X7蛋白稳定性,提示其通过结合并抑制P2X7受体发挥作用。
要点
- 柴胡皂苷可改善LPS诱导的小鼠抑郁样行为并减轻中枢炎症。
- 柴胡皂苷抑制神经元焦亡,其机制与结合并抑制P2X7受体相关。
- 该研究为柴胡类中药抗抑郁的现代药理学机制提供了实验依据。
核心结论
- 柴胡皂苷通过结合并抑制P2X7受体,减轻神经元焦亡并改善抑郁症状。
研究设计与样本
- 采用LPS腹腔注射建立小鼠抑郁体内模型,并以LPS和ATP诱导N9细胞建立体外模型。
- 通过HE染色、Nissl染色和Golgi染色评估各组小鼠抑郁治疗效果。
- 利用免疫荧光分析小胶质细胞活化以评价药物抗炎作用。
- 体外采用CCK-8法和乳酸脱氢酶法探究柴胡皂苷的治疗效果。
- 通过Western blot和免疫组化检测P2X7及凋亡相关蛋白表达,并引入P2X7激动剂BzATP,采用CETSA和CHX脉冲追踪实验验证柴胡皂苷与P2X7的结合作用及稳定性。
主要发现
- 通过Unifi在柴胡中鉴定出57种三萜皂苷类化合物。
- 在体内和体外模型中,柴胡皂苷均显著改善抑郁样行为、减轻中枢炎症并显著抑制小鼠神经元焦亡。
- 柴胡皂苷可显著降低抑郁小鼠脑内P2X7表达,并增强N9细胞中P2X7蛋白的稳定性。
临床怎么用
- 提示柴胡及其皂苷类成分可能通过抑制P2X7受体介导的焦亡通路发挥抗抑郁作用,为临床遣方用药提供机制参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The major depressive disorder (MDD) is a heterogeneous condition and characterized by a high recurrence rate, with neuroinflammation playing a significant role in its various potential pathologies. In recent years, neuronal pyroptosis induced by neuroinflammation has garnered increasing attention in depression research. Bupleurum scorzonerifolium Willd. is depression research in traditional Chinese medicine prescriptions to treat depression and exhibits notable anti-inflammatory properties. Saikosaponins (SSs) are the primary active components of Bupleurum scorzonerifolium Willd., although their mechanism of action in relation to anti-depressive effects remains unclear. PURPOSE: The purpose is to evaluate the efficacy of Chinese herbal medicine in treating depression through the lens of modern pharmacology. Additionally, it aims to explore the potential value of new mechanisms in the treatment of depression. STUDY DESIGN AND METHODS: An in vivo model of depression was established by intraperitoneal injection of LPS. HE staining, Nissl staining, and Golgi staining were used to evaluate the effectiveness of depression treatments in each group of mice. The activation of microglia was analyzed using immunofluorescence to evaluate the anti-inflammatory effects of drugs. In vitro models, N9 cells induced by LPS and ATP used CCK-8 assay, and lactate dehydrogenase assay were conducted to explore the therapeutic effect of the SSs. Western blot and immunohistochemical methods were employed to investigate the expression of P2X7 and apoptosis-related proteins. BzATP was introduced as a P2X7 agonist, and CETSA and CHX pulse-chase assay were utilized to verify the combined action and stability of the SSs with P2X7. RESULTS: 57 triterpenoid saponin compounds were identified by Unifi in Bupleurum scorzonerifolium Willd. In both in vivo and in vitro models, the SSs has been shown to significantly improve depression-like behavior, reduce central inflammation, and significantly inhibit neuronal pyroptosis in mice. The SSs can significantly decrease the expression of P2X7 in the brains of depressed mice and enhance the stability of P2X7 protein in N9 cells. CONCLUSION: SSs in Bupleurum scorzonerifolium Willd. bind and inhibit the P2X7 receptor to alleviate neuronal pyroptosis and improve symptoms of depression.
引用
- Bi Y, Li M, Wang Y, et al. Saikosaponins from Bupleurum scorzonerifolium Willd. alleviates microglial pyroptosis in depression by binding and inhibiting P2X7 expression. Phytomedicine. 2024. PMID: 39637473. doi:10.1016/j.phymed.2024.156240
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。